The MYO3A gene helps the tiny sound sensing hair cells in the inner ear keep their shape and do their job. If the MYO3A gene does not work properly, these cells may become less effective over time, which can lead to hearing loss that is often progressive. Some people with variants in the MYO3A gene notice trouble hearing higher pitched sounds first, while balance and other body systems are usually not affected. This gene is mainly known in hearing genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for producing proteins, which do much of the cell’s work. Others mainly guide when specific processes happen, where they happen, and how active they are. In combination, genes affect how your body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
MYO3AGene function
What if the gene works
The MYO3A gene helps inner ear hearing cells build and maintain the tiny hairlike structures that detect sound. It also supports similar cell structures in the eye.
Risk
What if the gene does not work
Changes in the MYO3A gene can cause hearing loss, usually without other body changes. It may start in childhood or adulthood and range from mild to marked, depending on the variant and whether one or both copies are affected.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the MYO3A gene does not currently lead to a gene-specific treatment or medication choice. Research is exploring how the MYO3A gene affects inner ear cells, but this has not yet changed clinical care.
Conditions associated with MYO3A
Gene function
What if the gene works
Inside the inner ear, the MYO3A gene helps tiny sound sensing cells keep their shape and do their job. It makes a motor protein that travels along actin, a support fiber inside cells, and brings key materials to the tips of small projections. This helps explain how the MYO3A gene supports hearing cell function during everyday sound detection.
Inside sound sensing cells, MYO3A acts like a small motor that moves along actin, a protein fiber that helps give cells shape. This motion brings materials to places that need steady upkeep.
One of its main jobs is to carry proteins toward the tips of the cell’s tiny projections. Keeping those tips supplied supports the precise structure used to pick up sound.
MYO3A helps maintain the actin core inside these projections. With this routine support, they keep a stable length and arrangement that helps hearing cells work smoothly.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MYO3A gene can change the shape, stability, or movement of the myosin IIIA protein, so it may not reach the tips of inner ear hair cells or work normally there. In practice, how MYO3A gene variants affect protein function depends on the change: some partly reduce activity, while more severe variants can truncate the protein or stop it being made. This range often matches milder or earlier-onset hearing loss.
How variants are linked to conditions
Pathogenic variants in the MYO3A gene are linked to inherited nonsyndromic hearing loss, meaning hearing loss without other consistent features in the rest of the body. Most well-established cases involve recessive hearing loss, where a person inherits one pathogenic variant from each parent. Rarer families have dominant progressive hearing loss from a single MYO3A gene variant. This reflects the main evidence on MYO3A gene variants linked to hearing loss.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct impact on health and are simply part of normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some instances, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the MYO3A gene. For people with a disease-causing MYO3A change, risk is mainly shaped by the genetic variant itself, while avoiding excessive noise may still help protect remaining hearing.
Inheritance of MYO3A variants
MYO3A-related hearing loss can be inherited in more than one way, so the MYO3A inheritance pattern depends on the specific variant and condition. Most often, MYO3A-related hearing loss follows an autosomal recessive pattern, which means a child inherits one altered copy from each parent. More rarely, some MYO3A variants are linked to autosomal dominant hearing loss, where one altered copy from either parent can be enough to cause the condition. Because the MYO3A gene is on chromosome 10, an autosome, it can be passed from either mother or father to sons or daughters.
What does my MYO3A result mean for my family?
MYO3A results can have different meanings for family members because this gene is linked to more than one inherited form of hearing loss. In some families, close relatives may also have hearing loss or may want to learn whether they carry the same gene change. In other families, relatives may be healthy carriers who could still pass the change on to children. The family impact depends on the exact MYO3A variant and which hearing-loss pattern it causes.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MYO3A variants usually uses a blood or saliva sample to read the DNA sequence of the MYO3A gene. It can show whether you carry a variant linked to inherited hearing loss and may be done as a single gene test or as part of a hearing loss panel.
When should I consider getting a genetic test?
Consider testing for the MYO3A gene if you or your child has unexplained hearing loss, especially if it began early in life, gets worse over time, or runs in the family. Finding a change in MYO3A can help explain the cause and clarify the chance for other relatives to be affected.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies by the condition and the kind of variant present. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how people respond to medicines. Small differences in the genes involved in taking in, breaking down, moving, or responding to a drug can change how much of that medicine reaches the body and how strongly it acts. This helps explain why the same treatment works well for one person, does less for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medication. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. With many medicines, genes affect both how strongly a drug works and how the body processes it. This information can help support more informed and individualized treatment decisions. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the MYO3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, changes in treatment, or new symptoms are best discussed with your doctor.
History
In recent decades, awareness of the MYO3A gene’s role has grown through research on inherited hearing loss. MYO3A was identified in the early 2000s as a cause of a form of nonsyndromic hearing loss, meaning hearing loss that is not part of a broader condition. This was an important step because it linked a specific inherited pattern in some families to one gene. From these first observations, research expanded steadily. Later studies showed that different variants in the MYO3A gene can be associated with hearing changes that begin at different ages, which helped doctors and researchers better understand why hearing loss can vary so much from one family to another.